Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZ505 是一种选择性SMYD2抑制剂,IC50值为 0.12 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 739 | 现货 | ||
2 mg | ¥ 1,090 | 现货 | ||
5 mg | ¥ 1,800 | 现货 | ||
10 mg | ¥ 2,920 | 现货 | ||
25 mg | ¥ 5,230 | 现货 | ||
50 mg | ¥ 7,390 | 现货 | ||
100 mg | ¥ 9,870 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,290 | 现货 |
产品描述 | AZ505 is an effective and specific SMYD2 inhibitor (IC50: 0.12 μM). |
靶点活性 | SMYD2:0.12 μM |
体外活性 | AZ505对SMYD2的IC50为0.12μM,这是对其他组蛋白甲基转移酶(如SMYD3(IC50>83.3μM)、DOT1L(IC50>83.3μM)和EZH2(IC50>83.3μM))IC50的>600倍[1]。AZ505未能抑制一系列蛋白质赖氨酸甲基转移酶的酶活性。AZ505被提名进行ITC结合研究,Kd为0.5μM。相比之下,p53底物肽的计算Kd为3.7μM[2]。 |
激酶实验 | SMYD2 is expressed in insect cells and purified. Methylation (12 μL) reactions are carried out in TDT buffer (50 mM Tris-HCl [pH 9.0], 2 mM DTT, and 0.01% Tween 20) at room temperature using 1.25 nM SMYD2 protein, 200 nM SAM, and 100 nM biotinylated p53 peptide substrate (Biotin-aminohexanoyl-GSRAHSSHLKSKKGQSTSRH) in low volume 384-well plates. Following a 75 min incubation period, reactions are quenched by the addition of 5 μL of detection solution (20 mM HEPES [pH 7.4], 1.7 mg/mL BSA, 340 mM NaCl, 680 μM SAH, 0.04 mg/mL Streptavidin-coated AlphaScreen donor, and Protein A-coated acceptor beads), and 1 nM of a custom p53K370me1 polyclonal antibody. Reaction plates are incubated overnight in the dark at room temperature and read using an Envision 2101 Multi-label Reader. Compounds showing >50% inhibition of SMYD2 are nominated for concentration dose-response determination and are also subjected to an artifact assay. Seven compound concentrations are selected beginning at 30 μM with six half-log dilution steps. The artifact assay conditions are identical to those in the SMYD2 enzymatic activity assay, except for the absence of SMYD2 protein and the presence of 1 nM methylated p53 peptide. IC50 values are calculated from dose-response data using in-house software [2]. |
分子量 | 577.54 |
分子式 | C29H38Cl2N4O4 |
CAS No. | 1035227-43-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (69.26 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.7315 mL | 8.6574 mL | 17.3148 mL | 43.287 mL |
5 mM | 0.3463 mL | 1.7315 mL | 3.463 mL | 8.6574 mL | |
10 mM | 0.1731 mL | 0.8657 mL | 1.7315 mL | 4.3287 mL | |
20 mM | 0.0866 mL | 0.4329 mL | 0.8657 mL | 2.1644 mL | |
50 mM | 0.0346 mL | 0.1731 mL | 0.3463 mL | 0.8657 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AZ505 1035227-43-0 Chromatin/Epigenetic Histone Methyltransferase inhibit Inhibitor AZ-505 AZ 505 inhibitor